Skip to main content
Top
Published in: Journal of Neuroinflammation 1/2011

Open Access 01-12-2011 | Research

Inhibitory effect of a tyrosine-fructose Maillard reaction product, 2,4-bis(p-hydroxyphenyl)-2-butenal on amyloid-β generation and inflammatory reactions via inhibition of NF-κB and STAT3 activation in cultured astrocytes and microglial BV-2 cells

Authors: Young-Jung Lee, Dong-Young Choi, Im Seup Choi, Jin-Yi Han, Heon-Sang Jeong, Sang Bae Han, Ki-Wan Oh, Jin Tae Hong

Published in: Journal of Neuroinflammation | Issue 1/2011

Login to get access

Abstract

Background

Amyloidogenesis is linked to neuroinflammation. The tyrosine-fructose Maillard reaction product, 2,4-bis(p-hydroxyphenyl)-2-butenal, possesses anti-inflammatory properties in cultured macrophages, and in an arthritis animal model. Because astrocytes and microglia are responsible for amyloidogenesis and inflammatory reactions in the brain, we investigated the anti-inflammatory and anti-amyloidogenic effects of 2,4-bis(p-hydroxyphenyl)-2-butenal in lipopolysaccharide (LPS)-stimulated astrocytes and microglial BV-2 cells.

Methods

Cultured astrocytes and microglial BV-2 cells were treated with LPS (1 μg/ml) for 24 h, in the presence (1, 2, 5 μM) or absence of 2,4-bis(p-hydroxyphenyl)-2-butenal, and harvested. We performed molecular biological analyses to determine the levels of inflammatory and amyloid-related proteins and molecules, cytokines, Aβ, and secretases activity. Nuclear factor-kappa B (NF-κB) DNA binding activity was determined using gel mobility shift assays.

Results

We found that 2,4-bis(p-hydroxyphenyl)-2-butenal (1, 2, 5 μM) suppresses the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) as well as the production of nitric oxide (NO), reactive oxygen species (ROS), tumor necrosis factor-α (TNF-α), and interleukin-1β (IL-1β) in LPS (1 μg/ml)-stimulated astrocytes and microglial BV-2 cells. Further, 2,4-bis(p-hydroxyphenyl)-2-butenal inhibited the transcriptional and DNA binding activity of NF-κB--a transcription factor that regulates genes involved in neuroinflammation and amyloidogenesis via inhibition of IκB degradation as well as nuclear translocation of p50 and p65. Consistent with the inhibitory effect on inflammatory reactions, 2,4-bis(p-hydroxyphenyl)-2-butenal inhibited LPS-elevated Aβ42 levels through attenuation of β- and γ-secretase activities. Moreover, studies using signal transducer and activator of transcription 3 (STAT3) siRNA and a pharmacological inhibitor showed that 2,4-bis(p-hydroxyphenyl)-2-butenal inhibits LPS-induced activation of STAT3.

Conclusions

These results indicate that 2,4-bis(p-hydroxyphenyl)-2-butenal inhibits neuroinflammatory reactions and amyloidogenesis through inhibition of NF-κB and STAT3 activation, and suggest that 2,4-bis(p-hydroxyphenyl)-2-butenal may be useful for the treatment of neuroinflammatory diseases like Alzheimer's disease.
Appendix
Available only for authorised users
Literature
1.
go back to reference Walsh DM, Selkoe DJ: A beta oligomers - a decade of discovery. J Neurochem. 2007, 101: 1172-1184. 10.1111/j.1471-4159.2006.04426.x.CrossRefPubMed Walsh DM, Selkoe DJ: A beta oligomers - a decade of discovery. J Neurochem. 2007, 101: 1172-1184. 10.1111/j.1471-4159.2006.04426.x.CrossRefPubMed
2.
go back to reference Pratico D, Trojanowski JQ: Inflammatory hypotheses: novel mechanisms of Alzheimer's neurodegeneration and new therapeutic targets?. Neurobiol Aging. 2000, 21: 441-445. 10.1016/S0197-4580(00)00141-X. discussion 451-453CrossRefPubMed Pratico D, Trojanowski JQ: Inflammatory hypotheses: novel mechanisms of Alzheimer's neurodegeneration and new therapeutic targets?. Neurobiol Aging. 2000, 21: 441-445. 10.1016/S0197-4580(00)00141-X. discussion 451-453CrossRefPubMed
3.
go back to reference Nichol KE, Poon WW, Parachikova AI, Cribbs DH, Glabe CG, Cotman CW: Exercise alters the immune profile in Tg2576 Alzheimer mice toward a response coincident with improved cognitive performance and decreased amyloid. J Neuroinflammation. 2008, 5: 13-10.1186/1742-2094-5-13.PubMedCentralCrossRefPubMed Nichol KE, Poon WW, Parachikova AI, Cribbs DH, Glabe CG, Cotman CW: Exercise alters the immune profile in Tg2576 Alzheimer mice toward a response coincident with improved cognitive performance and decreased amyloid. J Neuroinflammation. 2008, 5: 13-10.1186/1742-2094-5-13.PubMedCentralCrossRefPubMed
4.
go back to reference Maeda J, Ji B, Irie T, Tomiyama T, Maruyama M, Okauchi T, Staufenbiel M, Iwata N, Ono M, Saido TC, Suzuki K, Mori H, Higuchi M, Suhara T: Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography. J Neurosci. 2007, 27: 10957-10968. 10.1523/JNEUROSCI.0673-07.2007.CrossRefPubMed Maeda J, Ji B, Irie T, Tomiyama T, Maruyama M, Okauchi T, Staufenbiel M, Iwata N, Ono M, Saido TC, Suzuki K, Mori H, Higuchi M, Suhara T: Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography. J Neurosci. 2007, 27: 10957-10968. 10.1523/JNEUROSCI.0673-07.2007.CrossRefPubMed
5.
go back to reference Cho HJ, Kim SK, Jin SM, Hwang EM, Kim YS, Huh K, Mook-Jung I: IFN-gamma-induced BACE1 expression is mediated by activation of JAK2 and ERK1/2 signaling pathways and direct binding of STAT1 to BACE1 promoter in astrocytes. Glia. 2007, 55: 253-262. 10.1002/glia.20451.CrossRefPubMed Cho HJ, Kim SK, Jin SM, Hwang EM, Kim YS, Huh K, Mook-Jung I: IFN-gamma-induced BACE1 expression is mediated by activation of JAK2 and ERK1/2 signaling pathways and direct binding of STAT1 to BACE1 promoter in astrocytes. Glia. 2007, 55: 253-262. 10.1002/glia.20451.CrossRefPubMed
6.
go back to reference Heneka MT, O'Banion MK: Inflammatory processes in Alzheimer's disease. J Neuroimmunol. 2007, 184: 69-91. 10.1016/j.jneuroim.2006.11.017.CrossRefPubMed Heneka MT, O'Banion MK: Inflammatory processes in Alzheimer's disease. J Neuroimmunol. 2007, 184: 69-91. 10.1016/j.jneuroim.2006.11.017.CrossRefPubMed
7.
go back to reference Sastre M, Dewachter I, Landreth GE, Willson TM, Klockgether T, van Leuven F, Heneka MT: Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase. J Neurosci. 2003, 23: 9796-9804.PubMed Sastre M, Dewachter I, Landreth GE, Willson TM, Klockgether T, van Leuven F, Heneka MT: Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase. J Neurosci. 2003, 23: 9796-9804.PubMed
8.
go back to reference Miklossy J, Kis A, Radenovic A, Miller L, Forro L, Martins R, Reiss K, Darbinian N, Darekar P, Mihaly L, Khalili K: Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes. Neurobiol Aging. 2006, 27: 228-236. 10.1016/j.neurobiolaging.2005.01.018.CrossRefPubMed Miklossy J, Kis A, Radenovic A, Miller L, Forro L, Martins R, Reiss K, Darbinian N, Darekar P, Mihaly L, Khalili K: Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes. Neurobiol Aging. 2006, 27: 228-236. 10.1016/j.neurobiolaging.2005.01.018.CrossRefPubMed
9.
go back to reference Lee JW, Lee YK, Yuk DY, Choi DY, Ban SB, Oh KW, Hong JT: Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation. J Neuroinflammation. 2008, 5: 37-10.1186/1742-2094-5-37.PubMedCentralCrossRefPubMed Lee JW, Lee YK, Yuk DY, Choi DY, Ban SB, Oh KW, Hong JT: Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation. J Neuroinflammation. 2008, 5: 37-10.1186/1742-2094-5-37.PubMedCentralCrossRefPubMed
10.
go back to reference Blasko I, Apochal A, Boeck G, Hartmann T, Grubeck-Loebenstein B, Ransmayr G: Ibuprofen decreases cytokine-induced amyloid beta production in neuronal cells. Neurobiol Dis. 2001, 8: 1094-1101. 10.1006/nbdi.2001.0451.CrossRefPubMed Blasko I, Apochal A, Boeck G, Hartmann T, Grubeck-Loebenstein B, Ransmayr G: Ibuprofen decreases cytokine-induced amyloid beta production in neuronal cells. Neurobiol Dis. 2001, 8: 1094-1101. 10.1006/nbdi.2001.0451.CrossRefPubMed
11.
go back to reference Yan Q, Zhang J, Liu H, Babu-Khan S, Vassar R, Biere AL, Citron M, Landreth G: Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease. J Neurosci. 2003, 23: 7504-7509.PubMed Yan Q, Zhang J, Liu H, Babu-Khan S, Vassar R, Biere AL, Citron M, Landreth G: Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease. J Neurosci. 2003, 23: 7504-7509.PubMed
12.
go back to reference Sung S, Yang H, Uryu K, Lee EB, Zhao L, Shineman D, Trojanowski JQ, Lee VM, Pratico D: Modulation of nuclear factor-kappa B activity by indomethacin influences A beta levels but not A beta precursor protein metabolism in a model of Alzheimer's disease. Am J Pathol. 2004, 165: 2197-2206. 10.1016/S0002-9440(10)63269-5.PubMedCentralCrossRefPubMed Sung S, Yang H, Uryu K, Lee EB, Zhao L, Shineman D, Trojanowski JQ, Lee VM, Pratico D: Modulation of nuclear factor-kappa B activity by indomethacin influences A beta levels but not A beta precursor protein metabolism in a model of Alzheimer's disease. Am J Pathol. 2004, 165: 2197-2206. 10.1016/S0002-9440(10)63269-5.PubMedCentralCrossRefPubMed
13.
go back to reference McGeer PL, Rogers J: Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology. 1992, 42: 447-449.CrossRefPubMed McGeer PL, Rogers J: Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology. 1992, 42: 447-449.CrossRefPubMed
14.
go back to reference Hobbs AJ, Higgs A, Moncada S: Inhibition of nitric oxide synthase as a potential therapeutic target. Annu Rev Pharmacol Toxicol. 1999, 39: 191-220. 10.1146/annurev.pharmtox.39.1.191.CrossRefPubMed Hobbs AJ, Higgs A, Moncada S: Inhibition of nitric oxide synthase as a potential therapeutic target. Annu Rev Pharmacol Toxicol. 1999, 39: 191-220. 10.1146/annurev.pharmtox.39.1.191.CrossRefPubMed
15.
go back to reference Luna-Medina R, Cortes-Canteli M, Alonso M, Santos A, Martinez A, Perez-Castillo A: Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation. J Biol Chem. 2005, 280: 21453-21462. 10.1074/jbc.M414390200.CrossRefPubMed Luna-Medina R, Cortes-Canteli M, Alonso M, Santos A, Martinez A, Perez-Castillo A: Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation. J Biol Chem. 2005, 280: 21453-21462. 10.1074/jbc.M414390200.CrossRefPubMed
16.
go back to reference Shibakawa YS, Sasaki Y, Goshima Y, Echigo N, Kamiya Y, Kurahashi K, Yamada Y, Andoh T: Effects of ketamine and propofol on inflammatory responses of primary glial cell cultures stimulated with lipopolysaccharide. Br J Anaesth. 2005, 95: 803-810. 10.1093/bja/aei256.CrossRefPubMed Shibakawa YS, Sasaki Y, Goshima Y, Echigo N, Kamiya Y, Kurahashi K, Yamada Y, Andoh T: Effects of ketamine and propofol on inflammatory responses of primary glial cell cultures stimulated with lipopolysaccharide. Br J Anaesth. 2005, 95: 803-810. 10.1093/bja/aei256.CrossRefPubMed
17.
go back to reference Yeo SJ, Yoon JG, Yi AK: Myeloid differentiation factor 88-dependent post-transcriptional regulation of cyclooxygenase-2 expression by CpG DNA: tumor necrosis factor-alpha receptor-associated factor 6, a diverging point in the Toll-like receptor 9-signaling. J Biol Chem. 2003, 278: 40590-40600. 10.1074/jbc.M306280200.CrossRefPubMed Yeo SJ, Yoon JG, Yi AK: Myeloid differentiation factor 88-dependent post-transcriptional regulation of cyclooxygenase-2 expression by CpG DNA: tumor necrosis factor-alpha receptor-associated factor 6, a diverging point in the Toll-like receptor 9-signaling. J Biol Chem. 2003, 278: 40590-40600. 10.1074/jbc.M306280200.CrossRefPubMed
18.
go back to reference Kim YM, Lee BS, Yi KY, Paik SG: Upstream NF-kappaB site is required for the maximal expression of mouse inducible nitric oxide synthase gene in interferon-gamma plus lipopolysaccharide-induced RAW 264.7 macrophages. Biochem Biophys Res Commun. 1997, 236: 655-660. 10.1006/bbrc.1997.7031.CrossRefPubMed Kim YM, Lee BS, Yi KY, Paik SG: Upstream NF-kappaB site is required for the maximal expression of mouse inducible nitric oxide synthase gene in interferon-gamma plus lipopolysaccharide-induced RAW 264.7 macrophages. Biochem Biophys Res Commun. 1997, 236: 655-660. 10.1006/bbrc.1997.7031.CrossRefPubMed
19.
go back to reference Kumar A, Takada Y, Boriek AM, Aggarwal BB: Nuclear factor-kappaB: its role in health and disease. J Mol Med. 2004, 82: 434-448.CrossRefPubMed Kumar A, Takada Y, Boriek AM, Aggarwal BB: Nuclear factor-kappaB: its role in health and disease. J Mol Med. 2004, 82: 434-448.CrossRefPubMed
20.
go back to reference Wen Y, Yu WH, Maloney B, Bailey J, Ma J, Marie I, Maurin T, Wang L, Figueroa H, Herman M, Krishnamurthy P, Liu L, Planel E, Lau LF, Lahiri DK, Duff K: Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing. Neuron. 2008, 57: 680-690. 10.1016/j.neuron.2008.02.024.PubMedCentralCrossRefPubMed Wen Y, Yu WH, Maloney B, Bailey J, Ma J, Marie I, Maurin T, Wang L, Figueroa H, Herman M, Krishnamurthy P, Liu L, Planel E, Lau LF, Lahiri DK, Duff K: Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing. Neuron. 2008, 57: 680-690. 10.1016/j.neuron.2008.02.024.PubMedCentralCrossRefPubMed
21.
go back to reference Hagihara K, Nishikawa T, Sugamata Y, Song J, Isobe T, Taga T, Yoshizaki K: Essential role of STAT3 in cytokine-driven NF-kappaB-mediated serum amyloid A gene expression. Genes Cells. 2005, 10: 1051-1063. 10.1111/j.1365-2443.2005.00900.x.CrossRefPubMed Hagihara K, Nishikawa T, Sugamata Y, Song J, Isobe T, Taga T, Yoshizaki K: Essential role of STAT3 in cytokine-driven NF-kappaB-mediated serum amyloid A gene expression. Genes Cells. 2005, 10: 1051-1063. 10.1111/j.1365-2443.2005.00900.x.CrossRefPubMed
22.
go back to reference Jing H, Kitts DD: Antioxidant activity of sugar-lysine Maillard reaction products in cell free and cell culture systems. Arch Biochem Biophys. 2004, 429: 154-163. 10.1016/j.abb.2004.06.019.CrossRefPubMed Jing H, Kitts DD: Antioxidant activity of sugar-lysine Maillard reaction products in cell free and cell culture systems. Arch Biochem Biophys. 2004, 429: 154-163. 10.1016/j.abb.2004.06.019.CrossRefPubMed
23.
go back to reference Wijewickreme AN, Krejpcio Z, Kitts DD: Hydroxyl Scavenging Activity of Glucose, Fructose, and Ribose-Lysine Model Maillard Products. J Food Science. 1999, 64: 457-461. 10.1111/j.1365-2621.1999.tb15062.x.CrossRef Wijewickreme AN, Krejpcio Z, Kitts DD: Hydroxyl Scavenging Activity of Glucose, Fructose, and Ribose-Lysine Model Maillard Products. J Food Science. 1999, 64: 457-461. 10.1111/j.1365-2621.1999.tb15062.x.CrossRef
24.
go back to reference Yen WJ, Wang BS, Chang LW, Duh PD: Antioxidant properties of roasted coffee residues. J Agric Food Chem. 2005, 53: 2658-2663. 10.1021/jf0402429.CrossRefPubMed Yen WJ, Wang BS, Chang LW, Duh PD: Antioxidant properties of roasted coffee residues. J Agric Food Chem. 2005, 53: 2658-2663. 10.1021/jf0402429.CrossRefPubMed
25.
go back to reference Yilmaz Y, Toledo R: Antioxidant activity of water-soluble Maillard reaction products. Food Chem. 2005, 93: 273-278. 10.1016/j.foodchem.2004.09.043.CrossRef Yilmaz Y, Toledo R: Antioxidant activity of water-soluble Maillard reaction products. Food Chem. 2005, 93: 273-278. 10.1016/j.foodchem.2004.09.043.CrossRef
26.
go back to reference Atrooz OM: The effects of Maillard reaction products on apple and potato polyphenoloxidase and their antioxidant activity. Int J Food Sci Technol. 2008, 43: 490-494. 10.1111/j.1365-2621.2006.01478.x.CrossRef Atrooz OM: The effects of Maillard reaction products on apple and potato polyphenoloxidase and their antioxidant activity. Int J Food Sci Technol. 2008, 43: 490-494. 10.1111/j.1365-2621.2006.01478.x.CrossRef
27.
go back to reference Yen GC, Tsai LC, Lii JD: Antimutagenic effect of Maillard browning products obtained from amino acids and sugars. Food Chem Toxicol. 1992, 30: 127-132.CrossRefPubMed Yen GC, Tsai LC, Lii JD: Antimutagenic effect of Maillard browning products obtained from amino acids and sugars. Food Chem Toxicol. 1992, 30: 127-132.CrossRefPubMed
28.
go back to reference Aeschbacher HU: Antimutagenic/anticarcinogenic food components. Prog Clin Biol Res. 1990, 347: 201-216.PubMed Aeschbacher HU: Antimutagenic/anticarcinogenic food components. Prog Clin Biol Res. 1990, 347: 201-216.PubMed
29.
go back to reference Morales FJ, Babbel MB: Antiradical efficiency of Maillard reaction mixtures in a hydrophilic media. J Agric Food Chem. 2002, 50: 2788-2792. 10.1021/jf011449u.CrossRefPubMed Morales FJ, Babbel MB: Antiradical efficiency of Maillard reaction mixtures in a hydrophilic media. J Agric Food Chem. 2002, 50: 2788-2792. 10.1021/jf011449u.CrossRefPubMed
30.
go back to reference Hwang IG, Kim HY, Woo KS, Hong JT, Hwang BY, Jung JK, Lee J, Jeong HS: Isolation and characterisation of an [alpha]-glucosidase inhibitory substance from fructose-tyrosine Maillard reaction products. Food Chem. 2011, 127: 122-126. 10.1016/j.foodchem.2010.12.099.CrossRef Hwang IG, Kim HY, Woo KS, Hong JT, Hwang BY, Jung JK, Lee J, Jeong HS: Isolation and characterisation of an [alpha]-glucosidase inhibitory substance from fructose-tyrosine Maillard reaction products. Food Chem. 2011, 127: 122-126. 10.1016/j.foodchem.2010.12.099.CrossRef
31.
go back to reference Nath J, Powledge A: Modulation of human neutrophil inflammatory responses by nitric oxide: studies in unprimed and LPS-primed cells. J Leukoc Biol. 1997, 62: 805-816.PubMed Nath J, Powledge A: Modulation of human neutrophil inflammatory responses by nitric oxide: studies in unprimed and LPS-primed cells. J Leukoc Biol. 1997, 62: 805-816.PubMed
32.
go back to reference Lee YJ, Choi IS, Park MH, Lee YM, Song JK, Kim YH, Kim KH, Hwang DY, Jeong JH, Yun YP, Oh KW, Jung JK, Han SB, Hong JT: 4-O-Methylhonokiol attenuates memory impairment in presenilin 2 mutant mice through reduction of oxidative damage and inactivation of astrocytes and the ERK pathway. Free Radic Biol Med. 2011, 50: 66-77. 10.1016/j.freeradbiomed.2010.10.698.CrossRefPubMed Lee YJ, Choi IS, Park MH, Lee YM, Song JK, Kim YH, Kim KH, Hwang DY, Jeong JH, Yun YP, Oh KW, Jung JK, Han SB, Hong JT: 4-O-Methylhonokiol attenuates memory impairment in presenilin 2 mutant mice through reduction of oxidative damage and inactivation of astrocytes and the ERK pathway. Free Radic Biol Med. 2011, 50: 66-77. 10.1016/j.freeradbiomed.2010.10.698.CrossRefPubMed
33.
go back to reference Lee YK, Yuk DY, Lee JW, Lee SY, Ha TY, Oh KW, Yun YP, Hong JT: (-)-Epigallocatechin-3-gallate prevents lipopolysaccharide-induced elevation of beta-amyloid generation and memory deficiency. Brain Res. 2008, 1250: 164-174.CrossRefPubMed Lee YK, Yuk DY, Lee JW, Lee SY, Ha TY, Oh KW, Yun YP, Hong JT: (-)-Epigallocatechin-3-gallate prevents lipopolysaccharide-induced elevation of beta-amyloid generation and memory deficiency. Brain Res. 2008, 1250: 164-174.CrossRefPubMed
34.
go back to reference Lim GP, Yang F, Chu T, Chen P, Beech W, Teter B, Tran T, Ubeda O, Ashe KH, Frautschy SA, Cole GM: Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci. 2000, 20: 5709-5714.PubMed Lim GP, Yang F, Chu T, Chen P, Beech W, Teter B, Tran T, Ubeda O, Ashe KH, Frautschy SA, Cole GM: Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci. 2000, 20: 5709-5714.PubMed
35.
go back to reference Blasko I, Marx F, Steiner E, Hartmann T, Grubeck-Loebenstein B: TNFalpha plus IFNgamma induce the production of Alzheimer beta-amyloid peptides and decrease the secretion of APPs. FASEB J. 1999, 13: 63-68.PubMed Blasko I, Marx F, Steiner E, Hartmann T, Grubeck-Loebenstein B: TNFalpha plus IFNgamma induce the production of Alzheimer beta-amyloid peptides and decrease the secretion of APPs. FASEB J. 1999, 13: 63-68.PubMed
36.
go back to reference Hirose Y, Imai Y, Nakajima K, Takemoto N, Toya S, Kohsaka S: Glial conditioned medium alters the expression of amyloid precursor protein in SH-SY5Y neuroblastoma cells. Biochem Biophys Res Commun. 1994, 198: 504-509. 10.1006/bbrc.1994.1074.CrossRefPubMed Hirose Y, Imai Y, Nakajima K, Takemoto N, Toya S, Kohsaka S: Glial conditioned medium alters the expression of amyloid precursor protein in SH-SY5Y neuroblastoma cells. Biochem Biophys Res Commun. 1994, 198: 504-509. 10.1006/bbrc.1994.1074.CrossRefPubMed
37.
go back to reference Buxbaum JD, Oishi M, Chen HI, Pinkas-Kramarski R, Jaffe EA, Gandy SE, Greengard P: Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor. Proc Natl Acad Sci USA. 1992, 89: 10075-10078. 10.1073/pnas.89.21.10075.PubMedCentralCrossRefPubMed Buxbaum JD, Oishi M, Chen HI, Pinkas-Kramarski R, Jaffe EA, Gandy SE, Greengard P: Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor. Proc Natl Acad Sci USA. 1992, 89: 10075-10078. 10.1073/pnas.89.21.10075.PubMedCentralCrossRefPubMed
38.
go back to reference Liao YF, Wang BJ, Cheng HT, Kuo LH, Wolfe MS: Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway. J Biol Chem. 2004, 279: 49523-49532. 10.1074/jbc.M402034200.CrossRefPubMed Liao YF, Wang BJ, Cheng HT, Kuo LH, Wolfe MS: Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway. J Biol Chem. 2004, 279: 49523-49532. 10.1074/jbc.M402034200.CrossRefPubMed
39.
go back to reference Rogers JT, Leiter LM, McPhee J, Cahill CM, Zhan SS, Potter H, Nilsson LN: Translation of the alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5'-untranslated region sequences. J Biol Chem. 1999, 274: 6421-6431. 10.1074/jbc.274.10.6421.CrossRefPubMed Rogers JT, Leiter LM, McPhee J, Cahill CM, Zhan SS, Potter H, Nilsson LN: Translation of the alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5'-untranslated region sequences. J Biol Chem. 1999, 274: 6421-6431. 10.1074/jbc.274.10.6421.CrossRefPubMed
40.
go back to reference Bourne KZ, Ferrari DC, Lange-Dohna C, Rossner S, Wood TG, Perez-Polo JR: Differential regulation of BACE1 promoter activity by nuclear factor-kappaB in neurons and glia upon exposure to beta-amyloid peptides. J Neurosci Res. 2007, 85: 1194-1204. 10.1002/jnr.21252.CrossRefPubMed Bourne KZ, Ferrari DC, Lange-Dohna C, Rossner S, Wood TG, Perez-Polo JR: Differential regulation of BACE1 promoter activity by nuclear factor-kappaB in neurons and glia upon exposure to beta-amyloid peptides. J Neurosci Res. 2007, 85: 1194-1204. 10.1002/jnr.21252.CrossRefPubMed
41.
go back to reference Grilli M, Ribola M, Alberici A, Valerio A, Memo M, Spano P: Identification and characterization of a kappa B/Rel binding site in the regulatory region of the amyloid precursor protein gene. J Biol Chem. 1995, 270: 26774-26777. 10.1074/jbc.270.45.26774.CrossRefPubMed Grilli M, Ribola M, Alberici A, Valerio A, Memo M, Spano P: Identification and characterization of a kappa B/Rel binding site in the regulatory region of the amyloid precursor protein gene. J Biol Chem. 1995, 270: 26774-26777. 10.1074/jbc.270.45.26774.CrossRefPubMed
42.
go back to reference Choi S, Kim JH, Roh EJ, Ko MJ, Jung JE, Kim HJ: Nuclear factor-kappaB activated by capacitative Ca2+ entry enhances muscarinic receptor-mediated soluble amyloid precursor protein (sAPPalpha) release in SH-SY5Y cells. J Biol Chem. 2006, 281: 12722-12728. 10.1074/jbc.M601018200.CrossRefPubMed Choi S, Kim JH, Roh EJ, Ko MJ, Jung JE, Kim HJ: Nuclear factor-kappaB activated by capacitative Ca2+ entry enhances muscarinic receptor-mediated soluble amyloid precursor protein (sAPPalpha) release in SH-SY5Y cells. J Biol Chem. 2006, 281: 12722-12728. 10.1074/jbc.M601018200.CrossRefPubMed
43.
go back to reference Sambamurti K, Kinsey R, Maloney B, Ge YW, Lahiri DK: Gene structure and organization of the human beta-secretase (BACE) promoter. FASEB J. 2004, 18: 1034-1036.PubMed Sambamurti K, Kinsey R, Maloney B, Ge YW, Lahiri DK: Gene structure and organization of the human beta-secretase (BACE) promoter. FASEB J. 2004, 18: 1034-1036.PubMed
44.
go back to reference Grilli M, Goffi F, Memo M, Spano P: Interleukin-1beta and glutamate activate the NF-kappaB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures. J Biol Chem. 1996, 271: 15002-15007. 10.1074/jbc.271.25.15002.CrossRefPubMed Grilli M, Goffi F, Memo M, Spano P: Interleukin-1beta and glutamate activate the NF-kappaB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures. J Biol Chem. 1996, 271: 15002-15007. 10.1074/jbc.271.25.15002.CrossRefPubMed
45.
go back to reference Zhao Q, Lee FS: The transcriptional activity of the APP intracellular domain-Fe65 complex is inhibited by activation of the NF-kappaB pathway. Biochemistry. 2003, 42: 3627-3634. 10.1021/bi027117f.CrossRefPubMed Zhao Q, Lee FS: The transcriptional activity of the APP intracellular domain-Fe65 complex is inhibited by activation of the NF-kappaB pathway. Biochemistry. 2003, 42: 3627-3634. 10.1021/bi027117f.CrossRefPubMed
46.
go back to reference Buggia-Prevot V, Sevalle J, Rossner S, Checler F: NFkappaB-dependent control of BACE1 promoter transactivation by Abeta42. J Biol Chem. 2008, 283: 10037-10047. 10.1074/jbc.M706579200.CrossRefPubMed Buggia-Prevot V, Sevalle J, Rossner S, Checler F: NFkappaB-dependent control of BACE1 promoter transactivation by Abeta42. J Biol Chem. 2008, 283: 10037-10047. 10.1074/jbc.M706579200.CrossRefPubMed
47.
go back to reference Krady JK, Lin HW, Liberto CM, Basu A, Kremlev SG, Levison SW: Ciliary neurotrophic factor and interleukin-6 differentially activate microglia. J Neurosci Res. 2008, 86: 1538-1547. 10.1002/jnr.21620.CrossRefPubMed Krady JK, Lin HW, Liberto CM, Basu A, Kremlev SG, Levison SW: Ciliary neurotrophic factor and interleukin-6 differentially activate microglia. J Neurosci Res. 2008, 86: 1538-1547. 10.1002/jnr.21620.CrossRefPubMed
48.
go back to reference Denlinger LC, Fisette PL, Garis KA, Kwon G, Vazquez-Torres A, Simon AD, Nguyen B, Proctor RA, Bertics PJ, Corbett JA: Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium. J Biol Chem. 1996, 271: 337-342. 10.1074/jbc.271.1.337.CrossRefPubMed Denlinger LC, Fisette PL, Garis KA, Kwon G, Vazquez-Torres A, Simon AD, Nguyen B, Proctor RA, Bertics PJ, Corbett JA: Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium. J Biol Chem. 1996, 271: 337-342. 10.1074/jbc.271.1.337.CrossRefPubMed
Metadata
Title
Inhibitory effect of a tyrosine-fructose Maillard reaction product, 2,4-bis(p-hydroxyphenyl)-2-butenal on amyloid-β generation and inflammatory reactions via inhibition of NF-κB and STAT3 activation in cultured astrocytes and microglial BV-2 cells
Authors
Young-Jung Lee
Dong-Young Choi
Im Seup Choi
Jin-Yi Han
Heon-Sang Jeong
Sang Bae Han
Ki-Wan Oh
Jin Tae Hong
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Journal of Neuroinflammation / Issue 1/2011
Electronic ISSN: 1742-2094
DOI
https://doi.org/10.1186/1742-2094-8-132

Other articles of this Issue 1/2011

Journal of Neuroinflammation 1/2011 Go to the issue